A股異動 | 科大智能漲近4% 控股公司已簽訂口罩生產線訂單
格隆匯3月9日丨科大智能(300222.SZ)午後漲幅擴大,現報11.2元,漲3.99%,暫成交4.9億元,最新總市值81億元。科大智能今日在互動平台表示,公司控股公司杭州新餘宏智能裝備有限公司第一代口罩生產線(每分鐘可生產口罩300到400只)截至目前已簽訂部分訂單。在此基礎上,研發團隊又進一步研發了每分鐘可產1000只口罩的生產設備,升級版的生產線智能化程度更高、材料使用更節省,預計將於近期完成組裝調試。目前口罩機市場仍處於供不應求狀態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.